Lin
Founded 2021 · 119 employees on LinkedIn · 8 known investors
Lin Health provides virtual, evidence-based behavioral healthcare for people with chronic pain, using the Collaborative Care model and a technology platform to address the underlying causes of pain rather than only symptoms. It serves patients in the United States and partners with organizations to deliver whole-person chronic pain care.
Also known as Lin Health · Lin Health Medical Group
Founders & leadership
Lin was founded in 2021 by Yehuda Kogan.

Investors · 8
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ADec 2025 · 2 sources
Proofpoint Capital (lead), aMoon, Mayo Clinic, NewHealth Ventures, Osage Venture Partners, Saban Ventures, Shoni Health Ventures, Viola Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Lin Health (lin.health) provides virtual chronic pain treatment built on brain- and nervous-system-based behavioral care rather than symptom-focused pain management. Patients work with a dedicated Pain Recovery Coach who guides a customized care plan in coordination with a Lin Health physician, supported by a broader care team spanning interventional pain management, physical therapy, behavioral health and psychiatry. The clinical approach draws on Pain Reprocessing Therapy, Emotional Awareness and Expression Therapy, Cognitive Behavioral Therapy and other neuroplastic pain recovery techniques, combined with digital educational resources ("care kits"), an app and proprietary technology. The company frames its model around the ICD-11 diagnosis of chronic primary pain, which took effect in 2022 and recognizes that pain can be created or amplified by the brain and nervous system.
Lin treats a broad set of chronic pain conditions, including back pain, neck pain, joint pain, sciatica, fibromyalgia, migraine, IBS, pelvic pain, CRPS, POTS, TMJ, frozen shoulder, chronic tendonitis, plantar fasciitis and repetitive strain injuries. It targets patients whose pain is described as medically unexplained, whose back or joint pain has not resolved in three to six months, or who have multiple pain disorders. Care is positioned to providers and payers as a non-opioid, adjunctive treatment that expands capacity, shortens waiting times, reduces provider burnout, supports value-based outcomes and lowers total cost of care.
The company operates a medical group, Lin Health Medical Group, alongside coaching and technology operations, and lists a leadership team including CEO and co-founder Yehuda Kogan, CTO and co-founder Shahar Elias, co-founder and pain psychologist Abigail Hirsch, Chief Medical Officer Dr. Eric Anderson, Chief Commercial Officer Lily Rager, and Lin Health Medical Group President Dr. Jonah Mink, plus clinical, R&D, product and enterprise partnership executives.
Founding story
Lin Health was co-founded by CEO Yehuda Kogan, CTO Shahar Elias, and pain psychologist Abigail Hirsch, PhD.
Business model
Lin contracts with health systems, medical groups and health plans to make its chronic pain program available to their patients, and states it is in-network with most major insurance plans, including Medicare, so care is covered rather than paid entirely out of pocket. Patient-facing delivery combines coaching, telehealth physician oversight and digital content.
Care is billed through insurance coverage; Lin states it is in-network with major health plans and health systems in select states and that its care is covered by most major health plans including Medicare.
Traction
The company reports that 92% of patients see significant improvement in pain and function, a 45% reduction in pain intensity, 2-3 days of weekly patient engagement, and that 59% of patients joining with medium-to-high pain drop to low or no pain after six months, with only 1 in 10 still regularly experiencing high pain. Its website shows a 4.9 out of 5 patient review rating and lists collaborations with health systems and practices.
Latest developments
In December 2025 Lin Health announced an $11 million Series A led by Proofpoint Capital, with Osage Venture Partners and NewHealth Ventures joining as new investors and existing backers aMoon, Mayo Clinic, Saban Ventures, Shoni Health Ventures and Viola Ventures participating; the capital is intended for operational expansion and product development.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Lin positions itself as an early provider of chronic pain care aligned to the ICD-11 chronic primary pain classification, offering a non-opioid alternative and adjunct to conventional pain management; its medical advisor Dr. Shaheen Lakhan states Lin is one of the first companies to offer care based on the updated ICD-11 code.
Differentiators cited by the company include brain-based, behavioral treatment of primary pain instead of symptom management, integrated coaching plus physician and multidisciplinary oversight, insurance coverage and in-network status, and rapid scheduling with patients able to start within days.
Technology
A proprietary technology platform and patient app deliver digital pain education resources, high-frequency coaching and multidisciplinary clinical guidance; the intervention targets nervous system pain signaling and is described by the company as clinically validated.
Go-to-market
The company sells through partnerships with health systems, medical groups and health plans, supported by dedicated clinical partnerships teams including state-focused roles in Texas and California, while also recruiting Pain Recovery Coaches and accepting direct patient inquiries through its website.
Adults in the United States with persistent or medically unexplained chronic pain, reached via the health systems, medical groups and health plans that contract with Lin.
Geography
United States; the company states its care is covered by major insurance providers in Texas, Colorado, Florida and Maine, and it is in-network with major plans and health systems in select states. Press coverage describes the company as based in Denver, Colorado.
History
The company built a virtual chronic pain program around behavioral and brain-based treatment, established the Lin Health Medical Group with employed and consulting clinicians, secured in-network insurance coverage in several states, and announced an $11 million Series A round in December 2025 led by Proofpoint Capital to expand operations and development.
Risks & controversies
Outcome figures cited by Lin, including pain reduction percentages and patient satisfaction, are company-reported. Insurance coverage and in-network status are limited to select states, which constrains patient access.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsLin Health, based in Denver, Colorado, raised $11 million in Series A funding led by Proofpoint Capital, with new investors Osage Venture Partners and NewHealth Ventures and existing investors aMoon, Mayo Clinic, Saban Ventures, Shoni Health Ventures and Viola Ventures. Proceeds were earmarked for expanding operations and development efforts.
$11M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Linlin.health · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Lin do?
- Lin Health delivers virtual, behavioral-health-based chronic pain treatment in partnership with health systems, medical groups and payers.
- Who founded Lin?
- Lin was founded by Yehuda Kogan in 2021.
- Who are Lin's investors?
- Lin's investors include Saban Ventures, Shoni Health Ventures, Viola Ventures, aMoon, Osage Venture Partners, Proofpoint Capital.


